Lot-to-Lot Consistency in IVD Raw Materials
Why a silent change between batches is the most expensive failure mode in assay development — and how to protect against it.
The hidden failure mode
Most assay failures caused by raw materials are not obvious contaminants; they are small differences in purity profile, glycosylation, activity or aggregate content between one batch and the next.
What to demand from a supplier
Per-lot CoA with the characterisation methods stated, retained samples from previous lots, advance notice of process changes, and a supplier willing to reserve a validated lot for your reorders.
Practical protection
Keep a reference aliquot of a qualified lot, re-test a small side-by-side on each new lot, and document the lot number in your experimental records so anomalies can be traced backwards.
Related materials
Human Recombinant Soluble ST2 (sST2 / IL1RL1) →Recombinant Cardiac Troponin I (cTnI) →Broad-Spectrum IVD Reagent Preservative →Request a Quote or Sample
Tell us your application, target purity and quantity — we reply within one business day.